0001818382-22-000093.txt : 20220613 0001818382-22-000093.hdr.sgml : 20220613 20220613162229 ACCESSION NUMBER: 0001818382-22-000093 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wallace Max N. CENTRAL INDEX KEY: 0001877453 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39532 FILM NUMBER: 221011895 MAIL ADDRESS: STREET 1: 210 WEST TRYON STREET CITY: HILLSBOROUGH STATE: NC ZIP: 27278 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Humacyte, Inc. CENTRAL INDEX KEY: 0001818382 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851763759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919-313-9633 MAIL ADDRESS: STREET 1: 2525 EAST NORTH CAROLINA HIGHWAY 54 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Alpha Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20200716 4 1 wf-form4_165515173318572.xml FORM 4 X0306 4 2022-06-09 0 0001818382 Humacyte, Inc. HUMA 0001877453 Wallace Max N. 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 1 0 0 0 Stock Options (right to buy) 4.34 2022-06-09 4 A 0 8500 0 A 2032-06-09 Common Stock 8500.0 8500 D The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026. /s/ Max N. Wallace by Dale A. Sander as Attorney-in-Fact 2022-06-13